CEO SUMMARY: For 10 years, three primary trends have reshaped the anatomic pathology profession. They are declining reimbursement, competition from physicians establishing in-office pathology labs, and a host of new government laws and regulations. More changes are coming, predicts one business expert in pathology. Those changes involve new Medicare payment models, along with opportunities for
CEO SUMMARY: By now, most pathologists and clinical laboratory administrators recognize that effective use of information technology will be a critical success factor as healthcare systems transform to do population health management and to use “big data” with value-based payment models. As the provider of laboratory information systems to hundreds of the nation’s major hospitals,
AT THE END OF EACH YEAR, IT IS GENERALLY EASY TO PICK OUT the stories of greatest significance for the lab industry during the previous 12 months. But what is often overlooked are the non-stories. These are the events that did not happen in the year, despite earlier occurrences and the momentum pushing certain trends
There is a new national group that has the goal of addressing diagnostic errors in medicine. It is called the Coalition to Improve Diagnosis and became opera- tional last month. The new group was organized by the Society to Improve Diagnosis in Medicine (SIDM). Eleven organizations are already part of the coalition along with two government partners, which are the Agency for Healthcare Research and Quality (AHRQ) and the Centers for Disease Control and Prevention (CDC).
ARE CLINICAL LABORATORIES and pathology groups prepared for ICD-10? Or, perhaps a better question to ask is this: Are Medicare Administrative Contractors prepared to switch to ICD-10 on October 1?
CEO SUMMARY: CMS wanted more power to cut the prices it pays for clinical lab testing. A significant part of the lab industry wanted more transparency and consistency in how CMS established coverage guidelines and prices for new lab tests. Congress appears to have attempted to craft a law intended to support both objectives. Now,
CEO SUMMARY: On December 6, the Centers for Medicare & Medicaid Services proposed to delay implementation of Meaningful Use (MU) Stage 2 until 2016. One reason is that only about 80 vendors have certified their products to MU Stage 2. That is a small proportion of the almost 900 vendors who hold MU Stage 1
Mayo Clinic is taking steps to more fully integrate its laboratory informatics. In a press release dated April 27, 2012, it stated that it had completed a multi- year implementation of a new laboratory information system (LIS). The new LIS supports both the Department of Laboratory Medicine and Pathology and Mayo Medical Laboratories (MML) and
CEO SUMMARY: Clinical laboratories and pathology groups have a new tool to use for interfacing their LIS (laboratory information systems) with the electronic health record (EHR) systems of their office-based physician clients. It is ELINCS, an IT standard designed to support electronic lab test orders and lab test reporting. The California HealthCare Foundation sponsored the
WE ARE ONLY 120 DAYS FROM IMPLEMENTING another round of programs mandated by the Patient Protection and Affordable Care Act (PPACA) of 2010 and associated legislation. Certain programs become effective on January 1, 2012.
On that date, the transition to HIPAA form 5010 takes effect. All clinical laboratories and pathology groups should be prepared for this